BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PLB-002 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PLB-002\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07304128-2685@assetmemo.bio
DTSTAMP:20261121T005429Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:PLB-002: Phase 1 readout est. (NCT07304128)
DESCRIPTION:PLB-002\, phase 1.\nStudy: A Study of PLB-002 in Advanced Solid
  Tumors\nEstimated primary completion: 30 June 2027. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/plb-002#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT07304128
URL:https://assetmemo.bio/drug/plb-002#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
